Investor login
Investor login

Strategies

Our investment teams have distinct strategies and focus on investing in mid-market companies in a variety of sectors in the US and Europe.

All strategies Bregal Sagemount BU Bregal Milestone Bregal Sphere Bregal Partners Bregal Anthos Bregal Secondaries

Our investment teams have distinct strategies and focus on investing in mid-market companies in a variety of sectors in the US and Europe.

Flexible capital and strategic assistance for market-leading companies in high-growth sectors in North America and Europe

Equity capital for mid-sized companies in the DACH region and Italy

Growth capital and strategic assistance to software companies throughout Europe

Impact platform investing in climate and nature-based solutions

Equity capital for founder-owned companies in consumer and multi-unit, food and beverage, and business services

Private equity primaries, co-investments, and secondaries across North America and Europe

Based in New York, the group will invest globally in both LP and GP-led transactions, leveraging Bregal’s GP relationships and network of eight offices worldwide

Responsibility

Our Approach Responsible Investment Report 2024-25 Responsible Investing Case Studies Employee Giving Bregal Helps Initiative
person working on tablet surrounded by greenery
General Header 6 Hands holding vegetables
General Header 8 Holding hands

Contact

Contact London, UK New York, USA Munich, Germany Milan, Italy Zug, Switzerland Dallas, USA Palo Alto, USA St Helier, Jersey Strassen, Luxembourg
Sagemount Linkedin Post Options (10)

Ennov

650+
CUSTOMERS

use Ennov's software

500+
THOUSAND

users across 30 countries

25+
YEARS

of company development

Industry: Healthcare IT & Services
Year invested: 2026
Status: Current
Location: France
Investment Strategy: Flagship
Visit Website

Ennov is a global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies.

Founded and headquartered in Paris, Ennov provides a unified compliance platform that serves as a centralized system of record for global life sciences organizations. The platform supports the management of content and data across key domains, including Regulatory, Quality, Commercial, Clinical, and Pharmacovigilance. Its integrated architecture and unified data model enables faster deployment, improved user adoption, consistent compliance, and AI-driven efficiency across global operations.

Sagemount Linkedin Post Options (10)

"Regulatory and quality workflows in life sciences are becoming increasingly complex, while the cost of managing them across disconnected systems continues to rise. Olivier and his team have spent more than two decades building a mission-critical solution that enables customers to not only manage but optimize their processes to achieve better business outcomes. We believe this opportunity is only accelerating with Ennov’s new AI products, and we’re excited to support the Company in its next phase of growth. "

Gene Yoon Profile Image

Gene Yoon

Managing Partner - Bregal Sagemount

Team

Our experienced global investment team seeks to create long-standing relationships and drive lasting impact within our portfolio companies, which are active across Europe and North America.

All people
People

RELATED